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Background: Vulnerable plaque in coronary artery can progress to plaque rupture and thrombosis, and have a strong potential to induce acute 
coronary syndrome. Many studies have demonstrated that metabolic syndrome (MS) is associated with increased risk for cardiovascular diseases 
and related mortalities. This study aimed to determine the predictive value of MS on the vulnerable plaque in the patients with stable angina 
pectoris.
Methods: From September 2007 to June 2010, a total of 239 patients with stable angina pectoris who underwent coronary angiogram and 
intravascular ultrasound were categorized into two groups: Vulnerable plaque (VP) group (n=28, 21 men, 60.9±9.5 years) and Non-VP group (n=211, 
133 men, 62.2±9.1 years). NCEP-ATP III guideline was used to determine the presence of MS and each components of MS were compared between 
two groups.
Results: VP group showed more frequent target lesion in ostium (p = 0.005) and proximal area (p = 0.014), and more abundant plaque burden 
(76.9±7.7% vs. 70.5±9.7%, p = 0.001) and lower level of Apo-A1 (117.5±20.6% vs. 125.8±20.2%, p = 0.043) than non-VP group. In addition, low 
high density lipoprotein (HDL) cholesterol level as the criteria of MS (male <40mg/dL, female <50mg/dL) was observed in VP group more than 
non-VP group (p = 0.039), but the prevalence of MS and other components of MS were not different between two groups. Multivariate analysis using 
Logistic regression for the presence of vulnerable plaque showed that the independent predictors are the low HDL cholesterol level (relative risk = 
2.998, 95% confidence interval = 1.185-7.583, p = 0.02) and abundant plaque burden (relative risk = 1.084, 95% confidence interval = 1.019-
1.153, p = 0.011).
Conclusion: Although MS was not the predictor of vulnerable plaque, low HDL cholesterol level as the criteria of MS was meaningfully associated 
with vulnerable plaque.
